HRAS and neoplasm: Therefore, the aim of this study was to determine the sensitivity and specificity of IHC using SP174 to detect RAS Q61R in CAA tumor tissue and a lack of immunoreactivity with OSCC, including tumors that harbor a closely related HRAS p.Q61L mutation.